🚨 We are conducting first-ever #EQ5D5L valuation study in #Nepal! Led by our own @SayemAhmed & funded by @EuroQol, this @hergbrunel @Bruneluni & @HERDIntl project supports evidence-based decisions as #HTA advances in Nepal.
A key step for #healtheconomics in Nepal & South Asia

#CCR26 89.7% of patients attended at least 1 ward based rehab session, and 74% post-discharge rehab session, comprising a median of 5 and 11.5 sessions respectively. The primary outcome (Eq5D5L at 90 days after hospital discharge) was higher in the intervention group than control

🛠️ Key Resources
1. TSD22 Updated: New guidance on 3L to 5L mapping
2. TSD23 Updated: Revised severity calculators
3. Value in Health: Summary paper on the expected impact of the move
Check out the full breakdown & reports: bit.ly/4bJkbNQ
#HealthEconomics #EQ5D5L

Fun fun fun - chronic illness clinic sent me the check in questionnaire again.

EQ5D5L - 0.093 (Score between -0.400 and 1.000. Higher is better.)

MSK - 16 (Score between 0 and 56. Higher is better.)

ReQoL-10 - 21.00 (Score between 0.00 and 40.00. Higher is better.)

It's fine... this is all […]

6/ Outcomes
👉 1️⃣ was #mRS at 90 days
👉 MoCA and EQ5D5L also assessed
👉 Inflammatory markers also monitored @8 time points

Using data from 11 Asian countries this #preprint illustrates heterogeneity of health preferences across populations (#EQ5D5L):

Particularly w view to the relative importance of the five dimensions 👇

#HealthEconomics #Utilities

🛠️ Key Resources
1. TSD22 Updated: New guidance on 3L to 5L mapping
2. TSD23 Updated: Revised severity calculators
3. Value in Health: Summary paper on the expected impact of the move
Check out the full breakdown & reports: bit.ly/4bJkbNQ
#HealthEconomics #EQ5D5L

Gleichzeitig sind die zwei Items, die sich am stärksten verändern, im deutschen Value Set für den EQ5D5L auch die, die QALYs am meisten reduzieren, nämlich Schmerzen und körperliche Beschwerden und Angst/Depression.